Transient Anti-Phospholipid Antibodies in Two Patients With COVID-19

We report two cases of coronavirus disease 2019 (COVID-19) in patients who developed pulmonary embolism and transient anti-phospholipid antibodies. At the time of presentation with acute pulmonary embolism, both patients had leukocytosis and increased levels of anti-cardiolipin antibodies, which res...

Descripción completa

Detalles Bibliográficos
Autores principales: Balanchivadze, Nino, Xie, Peter, Kuriakose, Philip, Barthel, Bernd, Dabak, Vrushali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924965/
https://www.ncbi.nlm.nih.gov/pubmed/33665050
http://dx.doi.org/10.7759/cureus.13026
_version_ 1783659194858078208
author Balanchivadze, Nino
Xie, Peter
Kuriakose, Philip
Barthel, Bernd
Dabak, Vrushali
author_facet Balanchivadze, Nino
Xie, Peter
Kuriakose, Philip
Barthel, Bernd
Dabak, Vrushali
author_sort Balanchivadze, Nino
collection PubMed
description We report two cases of coronavirus disease 2019 (COVID-19) in patients who developed pulmonary embolism and transient anti-phospholipid antibodies. At the time of presentation with acute pulmonary embolism, both patients had leukocytosis and increased levels of anti-cardiolipin antibodies, which resolved at testing 12 weeks after initial presentation. Studying cases of pulmonary embolism and increased anti-phospholipid antibodies in the context of COVID-19 could be one of the factors for elucidating the possible connection between severe acute respiratory syndrome coronavirus 2 infection, anti-phospholipid antibodies, and thrombosis.
format Online
Article
Text
id pubmed-7924965
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-79249652021-03-03 Transient Anti-Phospholipid Antibodies in Two Patients With COVID-19 Balanchivadze, Nino Xie, Peter Kuriakose, Philip Barthel, Bernd Dabak, Vrushali Cureus Internal Medicine We report two cases of coronavirus disease 2019 (COVID-19) in patients who developed pulmonary embolism and transient anti-phospholipid antibodies. At the time of presentation with acute pulmonary embolism, both patients had leukocytosis and increased levels of anti-cardiolipin antibodies, which resolved at testing 12 weeks after initial presentation. Studying cases of pulmonary embolism and increased anti-phospholipid antibodies in the context of COVID-19 could be one of the factors for elucidating the possible connection between severe acute respiratory syndrome coronavirus 2 infection, anti-phospholipid antibodies, and thrombosis. Cureus 2021-01-31 /pmc/articles/PMC7924965/ /pubmed/33665050 http://dx.doi.org/10.7759/cureus.13026 Text en Copyright © 2021, Balanchivadze et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Balanchivadze, Nino
Xie, Peter
Kuriakose, Philip
Barthel, Bernd
Dabak, Vrushali
Transient Anti-Phospholipid Antibodies in Two Patients With COVID-19
title Transient Anti-Phospholipid Antibodies in Two Patients With COVID-19
title_full Transient Anti-Phospholipid Antibodies in Two Patients With COVID-19
title_fullStr Transient Anti-Phospholipid Antibodies in Two Patients With COVID-19
title_full_unstemmed Transient Anti-Phospholipid Antibodies in Two Patients With COVID-19
title_short Transient Anti-Phospholipid Antibodies in Two Patients With COVID-19
title_sort transient anti-phospholipid antibodies in two patients with covid-19
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924965/
https://www.ncbi.nlm.nih.gov/pubmed/33665050
http://dx.doi.org/10.7759/cureus.13026
work_keys_str_mv AT balanchivadzenino transientantiphospholipidantibodiesintwopatientswithcovid19
AT xiepeter transientantiphospholipidantibodiesintwopatientswithcovid19
AT kuriakosephilip transientantiphospholipidantibodiesintwopatientswithcovid19
AT barthelbernd transientantiphospholipidantibodiesintwopatientswithcovid19
AT dabakvrushali transientantiphospholipidantibodiesintwopatientswithcovid19

Ejemplares similares